Evidence map›Paper›PMID 40750659›Full record

ArticleScientific reports2025

Transparent brain tumor detection using DenseNet169 and LIME.

Lincy Annet Abraham, Gopinath Palanisamy, Goutham Veerapu

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lincy Annet AbrahamSchool of Electronics Engineering, Vellore Institute of Technology, Vellore, 632014, Tamilnadu, India.ORCID https://orcid.org/0009-0001-8223-5174
Gopinath PalanisamySchool of Electronics Engineering, Vellore Institute of Technology, Vellore, 632014, Tamilnadu, India. gopinath.p@vit.ac.in.ORCID https://orcid.org/0000-0002-9806-9473
Goutham VeerapuSchool of Electronics Engineering, Vellore Institute of Technology, Vellore, 632014, Tamilnadu, India.ORCID https://orcid.org/0000-0001-9277-465X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A crucial area of research in the field of medical imaging is that of brain tumor classification, which greatly aids diagnosis and facilitates treatment planning. This paper proposes DenseNet169-LIME-TumorNet, a model based on deep learning and an integrated combination of DenseNet169 with LIME to boost the performance of brain tumor classification and its interpretability. The model was trained and evaluated on the publicly available Brain Tumor MRI Dataset containing 2,870 images spanning three tumor types. Dense169-LIME-TumorNet achieves a classification accuracy of 98.78%, outperforming widely used architectures including Inception V3, ResNet50, MobileNet V2, EfficientNet variants, and other DenseNet configurations. The integration of LIME provides visual explanations that enhance transparency and reliability in clinical decision-making. Furthermore, the model demonstrates minimal computational overhead, enabling faster inference and deployment in resource-constrained clinical environments, thereby highlighting its practical utility for real-time diagnostic support. Work in the future should run towards creating generalization through the adoption of a multi-modal learning approach, hybrid deep learning development, and real-time application development for AI-assisted diagnosis.

Indexed as

Brain NeoplasmsDeep LearningMagnetic Resonance ImagingAlgorithmsCalcium CompoundsHumansOxidesCalcium CompoundslimeOxidesBrain tumor detectionDeep learningDenseNet169Local Interpretable Model-agnostic Explanations (LIME)Medical imagingTransfer learning

Identifiers

PMID40750659
PMCPMC12316994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.